Godavari Biorefineries sets Sep 28 for 71st AGM; e-voting starts Sep 25
- Godavari Biorefineries holds 71st AGM on September 28, 2026, via video conferencing
- Remote e-voting runs from September 25 to September 27, 2026
- FY26 revenue rose to ₹1,96,492.02 lakh from ₹185,316.64 lakh in FY25
- Company turned profitable with PAT of ₹123.62 lakh against prior year loss of ₹2,175.95 lakh
- Finance costs fell nearly 32.4% to ₹4,844.57 lakh, driving the turnaround

*this image is generated using AI for illustrative purposes only.
Godavari Biorefineries has scheduled its 71st Annual General Meeting for September 28, 2026. The meeting will be held at 11:30 am via video conferencing. Remote e-voting commences on September 25, 2026, and concludes on September 27, 2026. Shareholders holding shares as on September 21, 2026 are eligible to vote.
The company dispatched the annual report for FY26 to eligible members on September 4, 2026. The document is also available on the company website. The agenda includes the adoption of audited financial statements and several special resolutions regarding board appointments and remuneration approvals.
Financial Performance
The company reported a significant turnaround in profitability for FY26 compared to the previous year. Revenue from operations rose to ₹1,96,492.02 lakh from ₹185,316.64 lakh in FY25.
| Metric | FY26 | FY25 |
|---|---|---|
| Revenue from Operations | ₹1,96,492.02 lakh | ₹185,316.64 lakh |
| PBDIT | ₹13,453.40 lakh | ₹11,606.18 lakh |
| Finance Costs | ₹4,844.57 lakh | ₹7,160.79 lakh |
| PAT (Before OCI) | ₹123.62 lakh | (₹2,175.95) lakh |
Profit before depreciation, interest, exceptional items, and tax increased to ₹13,453.40 lakh from ₹11,606.18 lakh. Finance costs declined sharply to ₹4,844.57 lakh from ₹7,160.79 lakh, aiding the bottom line. The company returned to profit after tax, reporting ₹123.62 lakh against a loss of ₹2,175.95 lakh in the prior year.
What the Numbers Show
The shift from a substantial loss to a modest profit was driven primarily by a reduction in finance costs rather than an expansion in operating margins. While PBDIT grew by approximately 15.9%, finance costs fell by nearly 32.4%. This divergence suggests that interest cost management played a larger role in the turnaround than operational leverage during the period.
Board Appointments
The meeting will seek approval for the reappointment of Samir S. Somaiya as Managing Director for three years, effective April 1, 2027. His remuneration includes a basic salary of ₹17,95,360 per month and a commission of 2% of net profit.
Suhas Godage is proposed for reappointment as Whole-Time Director (Executive Director, Works-Sakarwadi) for three years starting April 1, 2027. His package includes a basic salary of ₹254,190 per month and a performance incentive capped at ₹20 lakh annually.
Dinesh Sharma will be appointed as a director and subsequently as Whole-Time Director (Executive Director, Works-Sameerwadi) effective from the date of the AGM. He currently serves as Chief Technical Officer at the Sameerwadi unit. His remuneration includes a basic salary of ₹255,030 per month.
Dr Raman Ramchandran and Suhas Godage are retiring by rotation and offer themselves for reappointment as directors.
Other Business
The company seeks ratification for the remuneration of cost auditor M/s R. Nanabhoy & Co., amounting to ₹6,40,000 per annum plus taxes for the financial year ending March 31, 2027.
Shareholders will also vote on contributing up to ₹1,40,00,000 to charitable and other funds in any financial year. Additionally, approval is sought for accepting fixed deposits from the public and members under three schemes offering interest rates between 8.50% and 9.50% per annum depending on tenure.
Historical Stock Returns for Godavari Biorefineries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.89% | -2.79% | -1.80% | -23.15% | -12.66% | -31.08% |
Can Godavari Biorefineries sustain its profitability in FY27 if operating margins do not improve, given that the recent turnaround was primarily driven by reduced finance costs rather than operational efficiency?
How will the appointment of Dinesh Sharma as Whole-Time Director for the Sameerwadi unit impact the operational synergy and cost structures between the Sakarwadi and Sameerwadi facilities?
What are the strategic implications of approving fixed deposit schemes with interest rates up to 9.50% in the current macroeconomic environment, and how might this affect the company's overall debt servicing capacity?


































